Breaking News Instant updates and real-time market news.

2022-07-07 06:36:08 THO Thor Industries $78.54 / -1.57 (-1.96%) 06:36 07/07/22 07/07 06:36 07/07/22 06:36	Thor Industries' Vice President of Investor Relations Mark Trinske to retire Thor Industries announced that Mark Trinske, Vice President of Investor Relations, will be retiring at the end of the company's fiscal year on July 31. As part of the planned transition, Michael Cieslak, CFA, Thor 's Investor Relations Manager will be responsible for Thor's investor relations efforts going forward. Cieslak joined the company in February 2020 with a background in investor relations and financial planning and analysis.

2022-07-07 06:36:08

THO

Thor Industries

$78.54 / -1.57 (-1.96%)

06:36

07/07/22

07/07

06:36

07/07/22

06:36

Thor Industries' Vice President of Investor Relations Mark Trinske to retire

Thor Industries announced that Mark Trinske, Vice President of Investor Relations, will be retiring at the end of the company's fiscal year on July 31. As part of the planned transition, Michael Cieslak, CFA, Thor 's Investor Relations Manager will be responsible for Thor's investor relations efforts going forward. Cieslak joined the company in February 2020 with a background in investor relations and financial planning and analysis.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Clearside Biomedical expects cash to fund operations into 2024 » 07:32 08/09/22 08/09 07:32 08/09/22 07:32 CLSD Clearside Biomedical $1.64 / -0.03 (-1.80%) As of June 30, 2022,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CLSD Clearside Biomedical $1.64 / -0.03 (-1.80%) 07/26/22 Clearside Biomedical completes dosing in OASIS Phase 1/2a trial of CLS-AX 06/14/22 Clearside Biomedical appoints Coultas as Chief Clinical Officer 05/05/22 Clearside Biomedical announces poster presentations at ARVO 2022 03/28/22 Bausch Health eye business, Clearside Biomedical announce Xipere launch CLSD Clearside Biomedical $1.64 / -0.03 (-1.80%) 12/22/21 Roth Capital Roth says Clearside data 'certainly supportive' of dose-escalation in Wet AMD 12/21/21 JMP Securities JMP remains bullish on Clearside as Cohort 2 in OASIS adds to CLS-AX potential 12/15/21 Wedbush Clearside Biomedical assumed with an Outperform at Wedbush 10/25/21 Roth Capital Clearside Biomedical price target raised to $17 from $15 at Roth Capital CLSD Clearside Biomedical $1.64 / -0.03 (-1.80%) 07:32 Today Clearside Biomedical reports Q2 EPS (13c), consensus (13c) 03/10/22 Clearside Biomedical reports Q4 EPS 31c, consensus 16c 00:00 Today Wedbush PacGrow Healthcare Virtual Conference 08:30 Today Clearside Biomedical - CLSD
Hot Stocks	Sophia Genetics sees cash runway through 2025 and beyond 07:32 08/09/22 08/09 07:32 08/09/22 07:32 SOPH Sophia Genetics $5.36 / +0.9 (+20.18%) ShowHide Related Items >><< Company News Street Research Earnings Events SOPH Sophia Genetics $5.36 / +0.9 (+20.18%) 06/06/22 Sophia Genetics provides update on DEEP-Lung-IV study at ASCO 2022 03/14/22 Sophia Genetics, REALM IDx sign LOI to collaborate on cancer research 03/09/22 Sophia Genetics' HRD testing technology adopted by Sofiva Genomics SOPH Sophia Genetics $5.36 / +0.9 (+20.18%) 10/14/21 Cowen Sophia Genetics coverage transferred at Cowen 08/17/21 Cowen Cowen starts 'emerging leader' Sophia Genetics with Outperform 08/17/21 Fly Intel: Top five analyst initiations 08/17/21 JPMorgan Sophia Genetics initiated with Overweight, $23 target at JPMorgan SOPH Sophia Genetics $5.36 / +0.9 (+20.18%) 07:31 Today Sophia Genetics reports Q2 adjusted EPS (31c) vs. (31c) last year 05/10/22 Sophia Genetics sees FY22 revenue low end of $51.5M-$54M 05/10/22 Sophia Genetics reports Q1 adjusted EPS (34c), consensus (33c) 03/15/22 Sophia Genetics sees FY22 revenue $51.5M-$54M, three estimates $52.94M 08/08/22 42nd Annual Global I Growth Conference 09/10/22 ESMO Congress 2022 08:30 Today Sophia Genetics - SOPH
Earnings	Clearside Biomedical reports Q2 EPS (13c), consensus (13c) » 07:32 08/09/22 08/09 07:32 08/09/22 07:32 CLSD Clearside Biomedical $1.64 / -0.03 (-1.80%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CLSD Clearside Biomedical $1.64 / -0.03 (-1.80%) 07/26/22 Clearside Biomedical completes dosing in OASIS Phase 1/2a trial of CLS-AX 06/14/22 Clearside Biomedical appoints Coultas as Chief Clinical Officer 05/05/22 Clearside Biomedical announces poster presentations at ARVO 2022 03/28/22 Bausch Health eye business, Clearside Biomedical announce Xipere launch CLSD Clearside Biomedical $1.64 / -0.03 (-1.80%) 12/22/21 Roth Capital Roth says Clearside data 'certainly supportive' of dose-escalation in Wet AMD 12/21/21 JMP Securities JMP remains bullish on Clearside as Cohort 2 in OASIS adds to CLS-AX potential 12/15/21 Wedbush Clearside Biomedical assumed with an Outperform at Wedbush 10/25/21 Roth Capital Clearside Biomedical price target raised to $17 from $15 at Roth Capital CLSD Clearside Biomedical $1.64 / -0.03 (-1.80%) 03/10/22 Clearside Biomedical reports Q4 EPS 31c, consensus 16c 00:00 Today Wedbush PacGrow Healthcare Virtual Conference 08:30 Today Clearside Biomedical - CLSD
Earnings	Sophia Genetics reports Q2 adjusted EPS (31c) vs. (31c) last year » 07:31 08/09/22 08/09 07:31 08/09/22 07:31 SOPH Sophia Genetics $5.36 / +0.9 (+20.18%) Reports Q2 revenue $11.7M… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SOPH Sophia Genetics $5.36 / +0.9 (+20.18%) 06/06/22 Sophia Genetics provides update on DEEP-Lung-IV study at ASCO 2022 03/14/22 Sophia Genetics, REALM IDx sign LOI to collaborate on cancer research 03/09/22 Sophia Genetics' HRD testing technology adopted by Sofiva Genomics SOPH Sophia Genetics $5.36 / +0.9 (+20.18%) 10/14/21 Cowen Sophia Genetics coverage transferred at Cowen 08/17/21 Cowen Cowen starts 'emerging leader' Sophia Genetics with Outperform 08/17/21 Fly Intel: Top five analyst initiations 08/17/21 JPMorgan Sophia Genetics initiated with Overweight, $23 target at JPMorgan SOPH Sophia Genetics $5.36 / +0.9 (+20.18%) 05/10/22 Sophia Genetics sees FY22 revenue low end of $51.5M-$54M 05/10/22 Sophia Genetics reports Q1 adjusted EPS (34c), consensus (33c) 03/15/22 Sophia Genetics sees FY22 revenue $51.5M-$54M, three estimates $52.94M 03/15/22 Sophia Genetics reports Q4 EPS (33c), three estimates (36c) 08/08/22 42nd Annual Global I Growth Conference 09/10/22 ESMO Congress 2022 08:30 Today Sophia Genetics - SOPH
Downgrade	Tattooed Chef downgraded to Neutral from Buy at Roth Capital » 07:31 08/09/22 08/09 07:31 08/09/22 07:31 TTCF Tattooed Chef $7.76 / +0.12 (+1.57%) Roth Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options TTCF Tattooed Chef $7.76 / +0.12 (+1.57%) 06/27/22 Tattooed Chef added to Russell Microcap Index 03/11/22 Tattooed Chef to restate 2021 quarterly financial statements 03/08/22 Tattooed Chef unveils innovation line-up for 2022 at Natural Products Expo West TTCF Tattooed Chef $7.76 / +0.12 (+1.57%) 05/10/22 Cowen Tattooed Chef price target lowered to $13 from $18 at Cowen 12/08/21 Cowen Tattooed Chef initiated with an Outperform at Cowen TTCF Tattooed Chef $7.76 / +0.12 (+1.57%) 08/08/22 Tattooed Chef sees FY22 revenue $ $280-$285, consensus $280.27M 08/08/22 Tattooed Chef reports Q2 EPS (32c) vs. (70c) last year 03/16/22 Tattooed Chef sees 2022 revenue $280M-$285M, consensus $282.99M 03/16/22 Tattooed Chef reports Q4 EPS (17c), consensus (8c) TTCF Tattooed Chef $7.76 / +0.12 (+1.57%) 03/28/22 Tattooed Chef call volume above normal and directionally bullish 03/15/22 Tattooed Chef call volume above normal and directionally bullish 03/10/22 Tattooed Chef put volume heavy and directionally bearish 03/01/22 Largest borrow rate increases among liquid names
Earnings	Reynolds Consumer Products sees Q3 adjusted EPS 20c-24c, consensus 43c » 07:31 08/09/22 08/09 07:31 08/09/22 07:31 REYN Reynolds Consumer Products $29.63 / +0.52 (+1.79%) Sees Q3 revenue up… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events REYN Reynolds Consumer Products $29.63 / +0.52 (+1.79%) 06/27/22 Citi Reynolds Consumer Products price target lowered to $28 from $31 at Citi 04/13/22 Stifel Reynolds Consumer Products downgraded to Hold at Stifel on higher input costs 04/13/22 Stifel Reynolds Consumer Products downgraded to Hold from Buy at Stifel 03/30/22 JPMorgan Reynolds Consumer Products price target lowered to $33 from $34 at JPMorgan REYN Reynolds Consumer Products $29.63 / +0.52 (+1.79%) 07:29 Today Reynolds Consumer Products reports Q2 adjusted EPS 26, consensus 25c 05/10/22 Reynolds Consumer Products sees Q2 EPS 23c-27c, consensus 39c 05/10/22 Reynolds Consumer Products reports Q1 EPS 26c, consensus 26c 02/09/22 Reynolds Consumer Products sees FY22 adjusted EPS $1.56-$1.70, consensus $1.73 REYN Reynolds Consumer Products $29.63 / +0.52 (+1.79%) 05/10/22 What You Missed On Wall Street On Tuesday 05/10/22 What You Missed On Wall Street This Morning 04/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/29/22 What You Missed On Wall Street On Tuesday 08:00 Today Reynolds Consumer Products - REYN
Earnings	InspireMD reports Q2 EPS (59c) vs (46c) last year » 07:31 08/09/22 08/09 07:31 08/09/22 07:31 NSPR InspireMD $2.05 / +0.045 (+2.25%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events NSPR InspireMD $2.05 / +0.045 (+2.25%) 07/14/22 InspireMD announces appointment of Parodi as strategic advisor to the company 06/09/22 InspireMD provides highlights from presentations at LINC 2022 06/02/22 InspireMD's CGuard Embolic Prevention System to be featured at LINC 2022 02/28/22 InspireMD announces inclusion of CGuard Carotid Stent in CREST-2 trial NSPR InspireMD $2.05 / +0.045 (+2.25%) 05/11/22 Alliance Global Partners InspireMD price target lowered to $5.25 from $9 at Alliance Global Partners 03/01/22 Alliance Global Partners InspireMD price target lowered to $9 from $16.50 at Alliance Global Partners NSPR InspireMD $2.05 / +0.045 (+2.25%) 05/10/22 InspireMD reports Q1 EPS (57c) vs. (53c) last year 03/08/22 InspireMD reports Q4 EPS (53c), one estimate (76c) 08:30 Today InspireMD - NSPR 08/31/22 InspireMD, Inc.
Downgrade	Turtle Beach downgraded to Perform on weaker outlook at Oppenheimer » 07:30 08/09/22 08/09 07:30 08/09/22 07:30 HEAR Turtle Beach $14.00 / -0.145 (-1.03%) Oppenheimer analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options HEAR Turtle Beach $14.00 / -0.145 (-1.03%) 08/08/22 Turtle Beach concludes proactive outreach to potential buyers 05/16/22 Turtle Beach reaches board refreshment agreement with Donerail Group 05/15/22 Fly Intel: Top five weekend stock stories 05/10/22 Turtle Beach launches Neat Microphones brand in Europe HEAR Turtle Beach $14.00 / -0.145 (-1.03%) 07:26 Today Wedbush Turtle Beach price target lowered to $12 from $22 at Wedbush 06:38 Today Oppenheimer Turtle Beach downgraded to Perform from Outperform at Oppenheimer 08/04/22 Wedbush Turtle Beach price target lowered to $22 from $27 at Wedbush 07/06/22 DA Davidson Turtle Beach price target lowered to $25 from $30 at DA Davidson HEAR Turtle Beach $14.00 / -0.145 (-1.03%) 08/08/22 Turtle Beach sees FY22 EPS ($1.35) to (90c), consensus 89c 08/08/22 Turtle Beach reports Q2 EPS ($1.08), consensus (38c) 05/04/22 Turtle Beach backs FY22 EPS view 70c-$1.20, consensus 89c 05/04/22 Turtle Beach reports Q1 adjusted EPS (39c), consensus (52c) HEAR Turtle Beach $14.00 / -0.145 (-1.03%) 05/15/22 Gaming gear provider Turtle Beach nears board deal with Donerail, Reuters says 03/22/22 Citron 'pounding table' on Turtle Beach, sees 'imminent' buyout 03/03/22 Citron highlights The Deal report of Turtle Beach weighing options HEAR Turtle Beach $14.00 / -0.145 (-1.03%) 08/08/22 Fly Intel: After-Hours Movers 05/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/22/22 What You Missed On Wall Street On Tuesday 03/22/22 What You Missed On Wall Street This Morning HEAR Turtle Beach $14.00 / -0.145 (-1.03%) 06/17/22 Turtle Beach call volume above normal and directionally bullish 05/17/22 Unusual call flow in option market yesterday 05/16/22 Calls lead puts 1200 to one in Turtle Beach with focus on 20 strike 05/16/22 Unusually active option classes on open May 16th
Earnings	Vertex sees 2022 revenue $480M-$484M, consensus $481.26M » 07:30 08/09/22 08/09 07:30 08/09/22 07:30 VERX Vertex $12.69 / +0.83 (+7.00%) Cloud revenue growth of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events VERX Vertex $12.69 / +0.83 (+7.00%) 08/02/22 Vertex mid-year report highlights rising volatility in sales tax rates 02/16/22 Vertex Indirect Tax Chain Flow Accelerator certified by SAP VERX Vertex $12.69 / +0.83 (+7.00%) 07/14/22 Morgan Stanley Vertex price target lowered to $10 from $12 at Morgan Stanley 05/23/22 Jefferies Vertex price target lowered to $13.50 from $14.50 at Jefferies 03/10/22 Needham Vertex price target lowered to $19 from $30 at Needham 03/10/22 JMP Securities Vertex price target lowered to $28 from $36 at JMP Securities VERX Vertex $12.69 / +0.83 (+7.00%) 07:29 Today Vertex sees Q3 revenue $121.5M-$124M, consensus $122.86M 07:28 Today Vertex reports Q2 EPS 6c vs. 8c last year 05/10/22 Vertex sees Q2 revenue $116M-$117.5M, consensus $117.86M 05/10/22 Vertex sees FY22 revenue $479M-$483M, consensus $480.65M 12 Jan 08:30 Today Vertex - VERX
Earnings	BioXcel Therapeutics reports Q2 EPS ($1.35), consensus ($1.22) » 07:29 08/09/22 08/09 07:29 08/09/22 07:29 BTAI BioXcel Therapeutics $16.61 / +0.15 (+0.91%) As of June 30, 2022, cash… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BTAI BioXcel Therapeutics $16.61 / +0.15 (+0.91%) 08/01/22 BioXcel Therapeutics announces NIH NIDA grant to Columbia University 07/05/22 BioXcel Therapeutics appoints Michael Miller to board of directors 05/20/22 BioXcel announces updated presentation time at HC Wainwright conference 05/09/22 BioXcel Therapeutics announces upcoming milestones BTAI BioXcel Therapeutics $16.61 / +0.15 (+0.91%) 07/08/22 Canaccord BioXcel Therapeutics significant room for upside seen, says Canaccord 07/06/22 Mizuho BioXcel Therapeutics initiated with a Buy at Mizuho 05/23/22 H.C. Wainwright BioXcel Therapeutics price target lowered to $110 from $134 at H.C. Wainwright 05/13/22 Canaccord BioXcel Therapeutics price target lowered to $75 from $84 at Canaccord BTAI BioXcel Therapeutics $16.61 / +0.15 (+0.91%) 05/09/22 BioXcel Therapeutics reports Q1 EPS ($1.12), consensus ($1.15) 03/10/22 BioXcel Therapeutics reports Q4 EPS (93c), consensus ($1.10) BTAI BioXcel Therapeutics $16.61 / +0.15 (+0.91%) 04/06/22 Fly Intel: Pre-market Movers 08/08/22 42nd Annual Global I Growth Conference 08:30 Today BioXcel Therapeutics - BTAI

Earnings	Avrobio reports Q2 EPS (64c) vs.(74c) » 07:29 08/09/22 08/09 07:29 08/09/22 07:29 AVRO Avrobio $1.00 / +0.0061 (+0.62%) As of June 30, AVROBIO… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events AVRO Avrobio $1.00 / +0.0061 (+0.62%) 07/13/22 FDA grants Avrobio ODD for AVR-RD-05 for Hunter Syndrome 05/18/22 Avrobio announces preclinical data from AVR-RD-03 trial 04/11/22 TScan Therapeutics appoints Leiden Dworak as VP, finance 02/09/22 Avrobio reports interim data from AVR-RD-04 trial AVRO Avrobio $1.00 / +0.0061 (+0.62%) 05/11/22 Wedbush Avrobio price target lowered to $4 from $14 at Wedbush 05/11/22 Barclays Avrobio price target lowered to $4 from $6 at Barclays 01/06/22 Mizuho Avrobio price target lowered to $6 from $28 at Mizuho 01/05/22 Morgan Stanley Avrobio price target lowered to $3 from $7 at Morgan Stanley AVRO Avrobio $1.00 / +0.0061 (+0.62%) 05/10/22 Avrobio reports Q1 EPS (68c), consensus (59c) 03/17/22 Avrobio reports Q4 EPS (65c), consensus (74c) 00:00 Today Wedbush PacGrow Healthcare Virtual Conference
Earnings	Reynolds Consumer Products reports Q2 adjusted EPS 26, consensus 25c » 07:29 08/09/22 08/09 07:29 08/09/22 07:29 REYN Reynolds Consumer Products $29.63 / +0.52 (+1.79%) Reports Q2 revenue $917M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events REYN Reynolds Consumer Products $29.63 / +0.52 (+1.79%) 06/27/22 Citi Reynolds Consumer Products price target lowered to $28 from $31 at Citi 04/13/22 Stifel Reynolds Consumer Products downgraded to Hold at Stifel on higher input costs 04/13/22 Stifel Reynolds Consumer Products downgraded to Hold from Buy at Stifel 03/30/22 JPMorgan Reynolds Consumer Products price target lowered to $33 from $34 at JPMorgan REYN Reynolds Consumer Products $29.63 / +0.52 (+1.79%) 05/10/22 Reynolds Consumer Products sees Q2 EPS 23c-27c, consensus 39c 05/10/22 Reynolds Consumer Products reports Q1 EPS 26c, consensus 26c 02/09/22 Reynolds Consumer Products sees FY22 adjusted EPS $1.56-$1.70, consensus $1.73 02/09/22 Reynolds Consumer Products sees Q1 adjusted EPS 24c-28c, consensus 30c REYN Reynolds Consumer Products $29.63 / +0.52 (+1.79%) 05/10/22 What You Missed On Wall Street On Tuesday 05/10/22 What You Missed On Wall Street This Morning 04/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/29/22 What You Missed On Wall Street On Tuesday 08:00 Today Reynolds Consumer Products - REYN
Earnings	Vertex sees Q3 revenue $121.5M-$124M, consensus $122.86M » 07:29 08/09/22 08/09 07:29 08/09/22 07:29 VERX Vertex $12.69 / +0.83 (+7.00%) Adjusted EBITDA of $16.5… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events VERX Vertex $12.69 / +0.83 (+7.00%) 08/02/22 Vertex mid-year report highlights rising volatility in sales tax rates 02/16/22 Vertex Indirect Tax Chain Flow Accelerator certified by SAP VERX Vertex $12.69 / +0.83 (+7.00%) 07/14/22 Morgan Stanley Vertex price target lowered to $10 from $12 at Morgan Stanley 05/23/22 Jefferies Vertex price target lowered to $13.50 from $14.50 at Jefferies 03/10/22 Needham Vertex price target lowered to $19 from $30 at Needham 03/10/22 JMP Securities Vertex price target lowered to $28 from $36 at JMP Securities VERX Vertex $12.69 / +0.83 (+7.00%) 07:28 Today Vertex reports Q2 EPS 6c vs. 8c last year 05/10/22 Vertex sees Q2 revenue $116M-$117.5M, consensus $117.86M 05/10/22 Vertex sees FY22 revenue $479M-$483M, consensus $480.65M 05/10/22 Vertex reports Q1 adjusted EPS 8c, consensus 6c 12 Jan 08:30 Today Vertex - VERX
Downgrade	Charter downgraded to Hold from Buy at Argus » 07:28 08/09/22 08/09 07:28 08/09/22 07:28 CHTR Charter / + Argus analyst Joseph… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CHTR Charter / + 07/29/22 Charter sees FY22 cable CapEx $7.1B-$7.3B 07/29/22 Charter: Q2 total residential, SMB mobile lines up 344,000 06/15/22 Charter CFO sees removal of around 60K-70K broadband customers on subsidy change 05/12/22 Marcien Jenckes named president of Comcast, Charter joint venture CHTR Charter / + 07:12 Today Argus Charter downgraded to Hold from Buy at Argus 08/01/22 Morgan Stanley Charter price target lowered to $550 from $600 at Morgan Stanley 08/01/22 Deutsche Bank Charter price target lowered to $550 from $575 at Deutsche Bank 08/01/22 Barclays Charter downgraded to Underweight from Equal Weight at Barclays CHTR Charter / + 07/29/22 Charter reports Q2 EPS $8.80, consensus $6.89 07/28/22 Notable companies reporting before tomorrow's open 07/28/22 Notable companies reporting before tomorrow's open 04/29/22 Charter reports Q1 EPS $6.90, consensus $6.47 CHTR Charter / + 08/04/22 Altice USA targeting PE funds in early Suddenlink negotiations, CNBC says 08/03/22 WideOpenWest, Suddenlink in talks with potential buyers, CNBC reports 07/27/22 Charter found liable for $7B in punitive damages for 2019 murder, WSJ reports CHTR Charter / + 08/01/22 What You Missed On Wall Street On Monday 08/01/22 What You Missed On Wall Street This Morning 08/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/01/22 Fly Intel: Pre-market Movers CHTR Charter / + 05/09/22 Early notable gainers among liquid option names on May 9th 03/03/22 Early notable gainers among liquid option names on March 3rd
Initiation	Tenaz Energy resumed with a Speculative Buy at Stifel » 07:28 08/09/22 08/09 07:28 08/09/22 07:28 ATUUF Tenaz Energy $1.45 / + (+0.00%) Stifel analyst Robert… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ATUUF Tenaz Energy $1.45 / + (+0.00%) 10/25/21 Stifel Tenaz Energy downgraded to Speculative Buy from Buy at Stifel
Recommendations	Monday.com price target raised to $180 from $150 at Cowen » 07:28 08/09/22 08/09 07:28 08/09/22 07:28 MNDY Monday.com $150.67 / +22.83 (+17.86%) Cowen analyst J. Derrick… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events MNDY Monday.com $150.67 / +22.83 (+17.86%) 05/16/22 Tiger Global buys Starry, exits Adobe in Q1 03/28/22 Cathie Wood's ARK Investment bought 43.6K shares of Monday.com today 03/02/22 Monday.com announces strategic alliance with KPMG MNDY Monday.com $150.67 / +22.83 (+17.86%) 08/08/22 Jefferies Monday.com price target raised to $140 from $115 at Jefferies 07/18/22 Piper Sandler Monday.com price target lowered to $150 from $200 at Piper Sandler 06/01/22 Tigress Financial Monday.com price target lowered to $240 from $432 at Tigress Financial 05/17/22 Cowen Monday.com price target lowered to $200 from $240 at Cowen MNDY Monday.com $150.67 / +22.83 (+17.86%) 08/08/22 Monday.com sees Q3 revenue $130M-$131M, consensus $125.74M 08/08/22 Monday.com reports Q2 EPS (33c), consensus (75c) 05/16/22 Monday.com raises FY22 revenue view to $488M-$492M from $470M-$475M 05/16/22 Monday.com sees Q2 revenue $117M-$119M, consensus $110.88M MNDY Monday.com $150.67 / +22.83 (+17.86%) 07/29/22 Sell these stocks now, proven algorithm says 06/17/22 Sell these stocks now, proven algorithm says 05/16/22 What You Missed On Wall Street On Monday 05/16/22 What You Missed On Wall Street This Morning 08/11/22 Monday.com
Earnings	Vertex reports Q2 EPS 6c vs. 8c last year » 07:28 08/09/22 08/09 07:28 08/09/22 07:28 VERX Vertex $12.69 / +0.83 (+7.00%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events VERX Vertex $12.69 / +0.83 (+7.00%) 08/02/22 Vertex mid-year report highlights rising volatility in sales tax rates 02/16/22 Vertex Indirect Tax Chain Flow Accelerator certified by SAP VERX Vertex $12.69 / +0.83 (+7.00%) 07/14/22 Morgan Stanley Vertex price target lowered to $10 from $12 at Morgan Stanley 05/23/22 Jefferies Vertex price target lowered to $13.50 from $14.50 at Jefferies 03/10/22 Needham Vertex price target lowered to $19 from $30 at Needham 03/10/22 JMP Securities Vertex price target lowered to $28 from $36 at JMP Securities VERX Vertex $12.69 / +0.83 (+7.00%) 05/10/22 Vertex sees Q2 revenue $116M-$117.5M, consensus $117.86M 05/10/22 Vertex sees FY22 revenue $479M-$483M, consensus $480.65M 05/10/22 Vertex reports Q1 adjusted EPS 8c, consensus 6c 03/09/22 Vertex sees 2022 revenue $479M-$483M, consensus $474.62M 12 Jan 08:30 Today Vertex - VERX
Recommendations	Qualys price target lowered to $150 from $160 at Wedbush » 07:28 08/09/22 08/09 07:28 08/09/22 07:28 QLYS Qualys $127.37 / -0.695 (-0.54%) Wedbush analyst Daniel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly QLYS Qualys $127.37 / -0.695 (-0.54%) 05/04/22 Qualys announces $200M increase to share repurchase program 05/03/22 Qualys, White Tuque partner to bolster cybersecurity offerings 02/23/22 Qualys appoints Arjet Skenduli as Chief Accounting Officer QLYS Qualys $127.37 / -0.695 (-0.54%) 08/08/22 Summit Insights Qualys sentiment to improve as revenue accelerates, says Summit Insights 07/26/22 Truist Qualys price target raised to $125 from $115 at Truist 07/15/22 DA Davidson Qualys initiated with a Neutral at DA Davidson 04/11/22 Wolfe Research Qualys initiated with an Outperform at Wolfe Research QLYS Qualys $127.37 / -0.695 (-0.54%) 08/08/22 Qualys raises FY22 non-GAAP EPS view to $3.50-$3.55 from $3.13-$3.17 08/08/22 Qualys sees Q3 non-GAAP EPS 85c-87c from 86c last year 08/08/22 Qualys reports Q2 non-GAAP EPS 89c, consensus 80c 05/04/22 Qualys raises FY22 adjusted EPS view to $3.13-$3.17 from $2.87-$2.92 QLYS Qualys $127.37 / -0.695 (-0.54%) 03/14/22 Israeli government sites crash in cyberattack, Haaretz reports QLYS Qualys $127.37 / -0.695 (-0.54%) 08/08/22 Fly Intel: After-Hours Movers 04/26/22 What Wall Street is saying about Alphabet ahead of earnings
Earnings	Cerence sees FY22 revenue $322M-$328M, consensus $370.89M » 07:28 08/09/22 08/09 07:28 08/09/22 07:28 CRNC Cerence $29.76 / +0.36 (+1.22%) Sees FY22 adjusted EBITDA… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CRNC Cerence $29.76 / +0.36 (+1.22%) 07/13/22 Cerence, CerebrumX collaborate to build AI-powered platform built on AWS 07/06/22 Cerence joins MIH Consortium to advance future for mobility 06/22/22 Lynk & Co selects Cerence to power conversation AI 05/17/22 SAIC Mobility Robotaxi selects Cerence for conversational interaction CRNC Cerence $29.76 / +0.36 (+1.22%) 07/07/22 RBC Capital Cerence upgraded to Sector Perform from Underperform at RBC Capital 05/18/22 Northland SoundHound replacing Cerence at Hyundai, says Northland 05/11/22 Craig-Hallum Cerence price target lowered to $45 from $52 at Craig-Hallum 05/11/22 Wedbush Cerence price target lowered to $32 from $45 at Wedbush CRNC Cerence $29.76 / +0.36 (+1.22%) 07:28 Today Cerence sees Q4 revenue $52M-$58M, consensus $98.46M 07:25 Today Cerence reports Q3 adjusted EPS 43c, consensus 42c 05/10/22 Cerence sees Q3 revenue $90M-$94M, consensus $91.62M 05/10/22 Cerence reports Q2 adjusted EPS 33c, consensus 34c 08:30 Today Cerence - CRNC
Earnings	Cerence sees Q4 revenue $52M-$58M, consensus $98.46M » 07:28 08/09/22 08/09 07:28 08/09/22 07:28 CRNC Cerence $29.76 / +0.36 (+1.22%) Q4 adjusted EBITDA is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CRNC Cerence $29.76 / +0.36 (+1.22%) 07/13/22 Cerence, CerebrumX collaborate to build AI-powered platform built on AWS 07/06/22 Cerence joins MIH Consortium to advance future for mobility 06/22/22 Lynk & Co selects Cerence to power conversation AI 05/17/22 SAIC Mobility Robotaxi selects Cerence for conversational interaction CRNC Cerence $29.76 / +0.36 (+1.22%) 07/07/22 RBC Capital Cerence upgraded to Sector Perform from Underperform at RBC Capital 05/18/22 Northland SoundHound replacing Cerence at Hyundai, says Northland 05/11/22 Craig-Hallum Cerence price target lowered to $45 from $52 at Craig-Hallum 05/11/22 Wedbush Cerence price target lowered to $32 from $45 at Wedbush CRNC Cerence $29.76 / +0.36 (+1.22%) 07:25 Today Cerence reports Q3 adjusted EPS 43c, consensus 42c 05/10/22 Cerence sees Q3 revenue $90M-$94M, consensus $91.62M 05/10/22 Cerence reports Q2 adjusted EPS 33c, consensus 34c 05/06/22 Cerence reports preliminary Q2 EPS 32c-33c, consensus 35c 08:30 Today Cerence - CRNC

Earnings	Healthcare Realty Trust reports Q2 normalized FFO 45c, consensus 45c » 07:27 08/09/22 08/09 07:27 08/09/22 07:27 HR Healthcare Realty Trust $25.35 / +0.24 (+0.96%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events HR Healthcare Realty Trust $25.35 / +0.24 (+0.96%) 07/21/22 Healthcare Trust to replace Healthcare Realty Trust in S&P 400 at open on 7/21 07/20/22 Healthcare Realty Trust, Healthcare Trust announce closing of merger agreement 07/19/22 Healthcare Realty Trust to be added to S&P MidCap 400 Index 07/15/22 Healthcare Realty shareholders approve Healthcare Trust merger HR Healthcare Realty Trust $25.35 / +0.24 (+0.96%) 05:03 Today Citi Healthcare Realty Trust resumed with a Neutral at Citi 07/21/22 JPMorgan Healthcare Realty Trust reinstated with a Neutral at JPMorgan 07/18/22 Credit Suisse Healthcare Realty Trust price target lowered to $29 from $34 at Credit Suisse 06/03/22 Capital One Healthcare Realty Trust reinstated with an Overweight at Capital One HR Healthcare Realty Trust $25.35 / +0.24 (+0.96%) 05/05/22 Healthcare Realty Trust reports Q1 normalized FFO 43c, consensus 45c 02/22/22 Healthcare Realty Trust reports Q4 normalized FFO 44c, consensus 44c HR Healthcare Realty Trust $25.35 / +0.24 (+0.96%) 05/03/22 Welltower remains interested in bid for Healthcare Realty Trust, WSJ reports HR Healthcare Realty Trust $25.35 / +0.24 (+0.96%) 05/03/22 What You Missed On Wall Street On Tuesday 05/03/22 What You Missed On Wall Street This Morning 02/28/22 What You Missed On Wall Street On Monday 02/28/22 What You Missed On Wall Street This Morning 12:00 Today Healthcare Realty Trust - HR
Earnings	Blade Air Mobility reports Q2 revenue $35.63M, consensus $37.98M » 07:27 08/09/22 08/09 07:27 08/09/22 07:27 BLDE Blade Air Mobility $6.22 / +0.095 (+1.55%) Reports Q2 flight margin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BLDE Blade Air Mobility $6.22 / +0.095 (+1.55%) 06/23/22 Blade Air Mobility to integrate airport service into JetBlue loyalty program 05/19/22 Blade to acquire transport activities of three air mobility operators for $50M 04/20/22 Blade Air Mobility announces creation of Blade Europe 04/11/22 Blade to provide service between LA and Indio for Festival in the Desert BLDE Blade Air Mobility $6.22 / +0.095 (+1.55%) 05/12/22 Deutsche Bank Blade Air Mobility price target lowered to $10 from $15 at Deutsche Bank 02/08/22 JPMorgan JPMorgan sees revenue beat for Blade Air Mobility on Thursday 01/31/22 Citi Blade Air Mobility price target lowered to $13 from $16 at Citi 12/21/21 Oppenheimer Blade Air Mobility price target lowered to $13 from $14 at Oppenheimer BLDE Blade Air Mobility $6.22 / +0.095 (+1.55%) 05/10/22 Blade Air Mobility reports Q1 EBITDA ($7.7M) vs. ($2.2M) last year 02/10/22 Blade Air Mobility reports Q4 revenue $24.6M, consensus $16.71M BLDE Blade Air Mobility $6.22 / +0.095 (+1.55%) 02/10/22 Fly Intel: After-Hours Movers 08/12/22 Annual Industrials, Energy & Airlines Conference 08:00 Today Blade Air Mobility - BLDE
Recommendations	Turtle Beach price target lowered to $12 from $22 at Wedbush » 07:26 08/09/22 08/09 07:26 08/09/22 07:26 HEAR Turtle Beach $14.00 / -0.145 (-1.03%) Wedbush analyst Michael… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options HEAR Turtle Beach $14.00 / -0.145 (-1.03%) 08/08/22 Turtle Beach concludes proactive outreach to potential buyers 05/16/22 Turtle Beach reaches board refreshment agreement with Donerail Group 05/15/22 Fly Intel: Top five weekend stock stories 05/10/22 Turtle Beach launches Neat Microphones brand in Europe HEAR Turtle Beach $14.00 / -0.145 (-1.03%) 06:38 Today Oppenheimer Turtle Beach downgraded to Perform from Outperform at Oppenheimer 08/04/22 Wedbush Turtle Beach price target lowered to $22 from $27 at Wedbush 07/06/22 DA Davidson Turtle Beach price target lowered to $25 from $30 at DA Davidson 05/17/22 Wedbush Wedbush upgrades Turtle Beach to Outperform on higher chance of deal HEAR Turtle Beach $14.00 / -0.145 (-1.03%) 08/08/22 Turtle Beach sees FY22 EPS ($1.35) to (90c), consensus 89c 08/08/22 Turtle Beach reports Q2 EPS ($1.08), consensus (38c) 05/04/22 Turtle Beach backs FY22 EPS view 70c-$1.20, consensus 89c 05/04/22 Turtle Beach reports Q1 adjusted EPS (39c), consensus (52c) HEAR Turtle Beach $14.00 / -0.145 (-1.03%) 05/15/22 Gaming gear provider Turtle Beach nears board deal with Donerail, Reuters says 03/22/22 Citron 'pounding table' on Turtle Beach, sees 'imminent' buyout 03/03/22 Citron highlights The Deal report of Turtle Beach weighing options HEAR Turtle Beach $14.00 / -0.145 (-1.03%) 08/08/22 Fly Intel: After-Hours Movers 05/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/22/22 What You Missed On Wall Street On Tuesday 03/22/22 What You Missed On Wall Street This Morning HEAR Turtle Beach $14.00 / -0.145 (-1.03%) 06/17/22 Turtle Beach call volume above normal and directionally bullish 05/17/22 Unusual call flow in option market yesterday 05/16/22 Calls lead puts 1200 to one in Turtle Beach with focus on 20 strike 05/16/22 Unusually active option classes on open May 16th
Hot Stocks	Nuvei sees 30%+ annual y-o-y growth for total volume in the medium term » 07:26 08/09/22 08/09 07:26 08/09/22 07:26 NVEI Nuvei $42.06 / +4.555 (+12.15%) Sees 30%+ annual y-o-y… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly NVEI Nuvei $42.06 / +4.555 (+12.15%) 08/02/22 Nuvei enters partnership with Selina 07/21/22 Eyas Gaming extends partnership with Nuvei 07/19/22 Nuvei announces partnership with Multi Wholesale Supplies 07/14/22 Nuvei announces it is extending its partnership with GoldBet NVEI Nuvei $42.06 / +4.555 (+12.15%) 07/22/22 Credit Suisse Nuvei downgraded to Neutral from Outperform at Credit Suisse 07/20/22 JPMorgan Nuvei price target lowered to $63 from $65 at JPMorgan 07/14/22 Goldman Sachs Nuvei downgraded to Neutral from Buy at Goldman Sachs 05/11/22 Canaccord Nuvei price target lowered to $85 from $110 at Canaccord NVEI Nuvei $42.06 / +4.555 (+12.15%) 07:24 Today Nuvei lowers 2022 revenue view $820M-$850M from $940M-$980M 07:22 Today Nuvei sees Q3 revenue $185M-$195M, consensus $232.47M 07:21 Today Nuvei reports Q2 adjusted EPS 51c, consensus 45c 05/10/22 Nuvei reaffirms FY22 revenue view $940M-$980M, consensus $968.8M 06 Oct NVEI Nuvei $42.06 / +4.555 (+12.15%) 07/08/22 Bet On It: Operators take stock as industry enters seasonally slowest months 03/28/22 What You Missed On Wall Street On Monday 03/28/22 What You Missed On Wall Street This Morning
Hot Stocks	Reata Pharmaceuticals: FDA extends review timeline for NDA for omaveloxolone » 07:26 08/09/22 08/09 07:26 08/09/22 07:26 RETA Reata Pharmaceuticals $24.02 / -11.895 (-33.12%) "Reata… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events RETA Reata Pharmaceuticals $24.02 / -11.895 (-33.12%) 08/08/22 Reata CEO looks forward to working with FDA on review of omaveloxone NDA 08/08/22 Reata Pharmaceuticals trading resumes 08/08/22 Reata Pharmaceuticals trading halted, volatility trading pause 05/26/22 Reata Pharmaceuticals' NDA for omaveloxolone granted Priority Review by FDA RETA Reata Pharmaceuticals $24.02 / -11.895 (-33.12%) 06:49 Today Baird Reata Pharmaceuticals price target lowered to $27 from $37 at Baird 08/08/22 Goldman Sachs Reata sinks on Friedreich's ataxia update but Goldman remains positive 08/08/22 Goldman Sachs Reata Pharmaceuticals price target raised to $76 from $73 at Goldman Sachs 05/27/22 Citi Reata Pharmaceuticals price target raised to $46 from $43 at Citi RETA Reata Pharmaceuticals $24.02 / -11.895 (-33.12%) 08/08/22 Reata Pharmaceuticals reports Q2 EPS ($2.02) , consensus ($2.02) 05/10/22 Reata Pharmaceuticals reports Q1 adjusted EPS ($1.33), consensus ($2.15) 02/28/22 Reata Pharmaceuticals reports Q4 EPS ($2.35), consensus ($2.31) RETA Reata Pharmaceuticals $24.02 / -11.895 (-33.12%) 08/08/22 What You Missed On Wall Street On Monday 08/08/22 What You Missed On Wall Street This Morning 02/28/22 What You Missed On Wall Street This Morning 11/30/22 PDUFA Date for Omaveloxolone

Events

Earnings calls, analyst events, roadshows and more

AXSM
Today at 08:00

Axsome Therapeutics - AXSM Conference Calls
KPLT
Today at 08:00

Katapult - KPLT Conference Calls
KLTR
Today at 08:00

Kaltura - KLTR Conference Calls
AVDL
Today at 08:00

Avadel Pharmaceuticals - AVDL Conference Calls
SDC
Today at 08:00

SmileDirectClub - SDC Conference Calls
REYN
Today at 08:00

Reynolds Consumer Products - REYN Conference Calls
ACM
Today at 08:00

Aecom - ACM Conference Calls
CBT
Today at 08:00

Cabot - CBT Conference Calls
CIFR
Today at 08:00

Cipher Mining - CIFR Conference Calls
PLNT
Today at 08:00

Planet Fitness - PLNT Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	BRBR X BRBR BellRing Brands Spot Secondary Managers: JPMorgan, Barclays, Citi, Goldman Sachs & Morgan Stanley Priced at: $23.50 14.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NUZE X NUZE NuZee Spot Secondary Managers: Maxim Priced at: $0.82 4.2M Shares PFLT X PFLT PennantPark Floating Rate Spot Secondary Managers: Morgan Stanley, Goldman Sachs, JPMorgan, Keefe Bruyette, RBC Capital & Truist Priced at: $12.40 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	AYTU X AYTU Aytu BioPharma Spot Secondary Managers: Cantor Fitzgerald & Canaccord $0.59 MDNA X MDNA Medicenna Therapeutics Spot Secondary Managers: Guggenheim, Bloom Burton Securities $1.45-1.55
Tues	CINC X CINC CinCor Pharma Secondary Managers: Goldman Sachs, Morgan Stanley, Jefferies & Piper Sandler $35.00 6M Shares KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan, Jefferies $241.19 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	FRZA X FRZA Forza X1 IPO Managers: ThinkEquity $5.00 3M Shares PTLO X PTLO Portillo's Secondary Managers: Jefferies & Morgan Stanley, BofA, Piper Sandler $28.44 8M Shares SOVO X SOVO Sovos Brands Secondary Managers: JPMorgan & Goldman Sachs, BofA, Credit Suisse, Barclays, UBS, Cowen, Piper Sandler, Stifel, William Blair, Telsey Advisory, Drexel Hamilton, Loop Capital $16.01 8.5M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Thor Industries' Vice President of Investor Relations Mark Trinske to retire

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access